Since PSA is also produced in subjects with inflammatory lesions of the prostate (such as benign prostatic hyperplasia), its use as diagnostic biomarker alone is insufficient to identify patients with PCa. The gene discussed is KLK3; the disease is posterior cortical atrophy.